Sign Up to like & get
recommendations!
2
Published in 2020 at "Intensive Care Medicine"
DOI: 10.1007/s00134-020-06141-z
Abstract: ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory failure. Despite considerable advances in our knowledge regarding the pathophysiology of ARDS, insights into the biologic mechanisms of lung injury and…
read more here.
Keywords:
medicine;
pharmacological therapies;
ards covid;
therapies ards ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0277000
Abstract: Background Hypercoagulability and thrombo-inflammation are the main reasons for death in COVID-19 patients. It is unclear whether there is a difference between D-dimer levels in patients without or with COVID-19 acute respiratory distress syndrome (ARDS).…
read more here.
Keywords:
non covid;
covid ards;
dimer levels;
ards covid ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Physiology"
DOI: 10.3389/fphys.2022.829534
Abstract: This review was designed to discuss the role of thoracic-computed tomography (CT) in the evaluation and treatment of patients with ARDS and COVID-19 lung disease. Non-aerated lungs characterize the ARDS lungs, compared to normal lungs…
read more here.
Keywords:
ards covid;
computed tomography;
tomography;
thoracic computed ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Medicina"
DOI: 10.3390/medicina58081104
Abstract: Background and Objectives: Background: Coronavirus disease 2019 (COVID-19) is a novel cause of Acute Respiratory Distress Syndrome (ARDS). Noninvasive ventilation (NIV) is widely used in patients with ARDS across several etiologies. Indeed, with the increase…
read more here.
Keywords:
covid patients;
ards covid;
third level;
noninvasive ventilation ... See more keywords